Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesFDA Approves New HIV Drug After Priority Review
FDA Press Releases , 01/22/08
The U.S. Food and Drug Administration today approved etravirine tablets for the treatment of HIV infection in adults who have failed treatment with other antiretrovirals. Etravirine is a non-nucleoside reverse transcriptase inhibitor (NNRTI) that helps to block an enzyme which HIV needs to multiply. The drug was approved to be used in combination with other anti-HIV medications. Sold under the trade name Intelence, etravirine received a priority review by the FDA
| Previous Article | Next Article |
Today in Drug/Product Alerts...keeping you current
Receive free subspecialty "5-minute updates" via email
Iloperidone (Fanapt): Psychotropic agent approved for the acute treatment of schizophrenia
Formulary , 06/08/09
FDA advisory panel makes favorable recommendation for ARZERRA (ofatumumab)
GlaxoSmithKline, 06/02/09
Allos Therapeutics Announces FDA Accepts Pralatrexate NDA for Filing and Grants the Application Priority Review Status
Allos Therapeutics, 05/27/09
Article Search
Sponsor